Literature DB >> 911658

Effects of cytotoxic agents on TdR incorporation and growth delay in human colonic tumour xenografts.

P J Houghton, J A Houghton, D M Taylor.   

Abstract

The relationship between the utilization of 3H-thymidine in situ ([3H]-TdR fractional incorporation or TFI) and tumour growth delay after treatment with various cytotoxic agents has been examined. It is shown that (a) it is not possible to predict tumour growth delay, or to select the most effective agent, from changes in TFI 1 day after treatment; (b) there is a good correlation between tumour growth delay and the time for recovery of TFI to the pretreatment level; (c) there is a relationship within a tumour line between the depression of TFI 4 days after treatment and growth dealy induced by the same treatment. This relationship appears to be independent of the mechanism by which the agent exerts its cytotoxic effect.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 911658      PMCID: PMC2025473          DOI: 10.1038/bjc.1977.179

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Commentary: screening for anti-cancer agents; the relative merits of in vitro and in vovo techniques.

Authors:  T A Connors; B J Phillips
Journal:  Biochem Pharmacol       Date:  1975-12-15       Impact factor: 5.858

2.  Effects of cis-dichlorodiammine platinum (II) on DNA synthesis in kidney and other tissues of normal and tumour-bearing rats.

Authors:  D M Taylor; K D Tew; J D Jones
Journal:  Eur J Cancer       Date:  1976-04       Impact factor: 9.162

3.  In vitro determination of thymidine-3H labeling index in human solid tumors.

Authors:  R B Livingston; U Ambus; S L George; E J Freireich; J S Hart
Journal:  Cancer Res       Date:  1974-06       Impact factor: 12.701

4.  Biochemical approaches to prediction of response in solid tumors.

Authors:  W H Wolberg
Journal:  Natl Cancer Inst Monogr       Date:  1971-12

5.  Growth inhibiting effects of cytotoxic agents on human tumor and tumor-bearing normal tissue in vitro.

Authors:  F C Izsak; E Eylan; A Gazith; J Shapiro; S Naharin; C Raanani
Journal:  Eur J Cancer       Date:  1971-02       Impact factor: 9.162

6.  Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease.

Authors:  T K Wheeler; P P Dendy; A Dawson
Journal:  Oncology       Date:  1974       Impact factor: 2.935

7.  Cell population kinetics of transplanted and metastatic Lewis lung carcinoma.

Authors:  L Simpson-Herren; A H Sanford; J P Holmquist
Journal:  Cell Tissue Kinet       Date:  1974-07

8.  Determination of therapeutic index of drugs by in vitro sensitivity tests using human host and tumor cell suspensions.

Authors:  G Tisman; V Herbert; H Edlis
Journal:  Cancer Chemother Rep       Date:  1973-02

9.  Serial labeling index determination as a predictor of response in human solid tumors.

Authors:  W K Murphy; R B Livingston; V G Ruiz; F G Gercovich; S L George; J S Hart; E J Freireich
Journal:  Cancer Res       Date:  1975-06       Impact factor: 12.701

10.  Walter Hubert lecture Chemotherapy of upper gastrointestinal carcinoma.

Authors:  C G Moertel
Journal:  Br J Cancer       Date:  1976-09       Impact factor: 7.640

View more
  8 in total

Review 1.  Predictive tests in cancer chemotherapy. A reappraisal.

Authors:  R Osieka; S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1984-03-01

2.  The mechanism of 67Ga uptake in animal and human tumours.

Authors:  P A Hammersley; D M Taylor; S Cronshaw
Journal:  Eur J Nucl Med       Date:  1980-10

3.  Serological aspects of rat tumour xenograft growth in athymic nude mice.

Authors:  M V Pimm; R W Baldwin
Journal:  Br J Cancer       Date:  1979-02       Impact factor: 7.640

4.  Assays of drug sensitivity for cells from human tumours: in vitro and in vivo tests on a xenografted tumour.

Authors:  A E Bateman; M J Peckham; G G Steel
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

5.  Serial cytogenetic studies of human colonic tumour xenografts.

Authors:  B R Reeves; J A Houghton
Journal:  Br J Cancer       Date:  1978-04       Impact factor: 7.640

6.  Maintenance of biological and biochemical characteristics of human colorectal tumours during serial passage in immune-deprived mice.

Authors:  J A Houghton; D M Taylor
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

7.  Growth characteristics of human colorectal tumours during serial passage in immune-deprived mice.

Authors:  J A Houghton; D M Taylor
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

Review 8.  Human tumour xenografts: a critical appraisal.

Authors:  G G Steel; M J Peckham
Journal:  Br J Cancer Suppl       Date:  1980-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.